Company
Anavex Life Sciences
Anavex Life Sciences has 4 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 2/3, 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ANAVEX2-73 | Phase 3 | Rett Syndrome |
| ANAVEX2-73 oral liquid | Phase 2/3 | Rett Syndrome |
| High dose ANAVEX2-73 | Phase 2/3 | Alzheimer Disease |
| ANAVEX3-71 oral capsules | Phase 2 | Schizophrenia |
Latest
- anavex life sciences filed 8-K
- anavex life sciences filed 8-K
- anavex life sciences filed 8-K
- anavex life sciences filed 8-K
- anavex life sciences filed 8-K
Follow Anavex Life Sciences on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.